- Home
- RPRX vs TW Comparison
RPRX vs TW Comparison
Compare RPRX & TW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | TW |
|---|---|---|
| Founded | 1996 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 22.7B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RPRX | TW |
|---|---|---|
| Price | $57.41 | $102.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 15 |
| Target Price | $65.13 | ★ $123.64 |
| AVG Volume (30 Days) | ★ 2.7M | 1.1M |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | ★ 1.61% | 0.56% |
| EPS Growth | N/A | ★ 62.23 |
| EPS | 0.71 | ★ 1.81 |
| Revenue | ★ $2,378,193,000.00 | $892,659,000.00 |
| Revenue This Year | $47.32 | $14.20 |
| Revenue Next Year | $8.70 | $11.49 |
| P/E Ratio | $82.08 | ★ $55.57 |
| Revenue Growth | 5.06 | ★ 15.10 |
| 52 Week Low | $35.23 | $91.42 |
| 52 Week High | $64.38 | $127.69 |
Technical Indicators
Market Signals| Indicator | RPRX | TW |
|---|---|---|
| Relative Strength Index (RSI) | 41.62 | 45.60 |
| Support Level | $57.75 | $96.95 |
| Resistance Level | $58.84 | $103.84 |
| Average True Range (ATR) | 1.07 | 2.12 |
| MACD | -0.12 | -0.15 |
| Stochastic Oscillator | 24.51 | 33.27 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About TW Tradeweb Markets Inc.
Founded in 1998 and headquartered in New York City, Tradeweb Markets is a leading fixed-income trading platform. While it does offer electronic processing for some voice-negotiated trades, the company focuses primarily on providing electronic trading networks that connect broker/dealers, institutional clients, and retail customers. While the company offers trading in a wide variety of products, the bulk of its business is in US and European government debt, mortgage-backed securities, interest-rate swaps, and US and international corporate bonds. The firm also sells fixed-income trading and price data, primarily through a deal with Refinitiv's Eikon service.